Parsabiv Injection, Solution
Product Images NDC 55513-741

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Parsabiv (NDC 55513-741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Etelcalcetide Hci. (Parsabiv 01)

Chemical structure of etelcalcetide, the active ingredient in PARSABIV. The diagram shows the molecular arrangement including peptide bonds, functional groups such as amide, guanidine, and disulfide, and the hydrochloride salt indicated as xHCl.*

FDA Label Image

Principal Display Panel10 X 0.5 mL Single-dose Vialsndc 55513-740-10amgen®parsabivtm (etelcalcetide)injection2.5 mg/0.5 mLfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 02)

Packaging label for Parsabiv (etelcalcetide) Injection, 2.5 mg/0.5 mL single-dose vial. The label indicates the product is for intravenous use after hemodialysis and comes in a box of 10 single-dose vials. It is sterile, preservative-free, and distributed by Amgen, Inc. Storage instructions and NDC 55513-740-10 are also shown.*

FDA Label Image

Principal Display Panel10 X 1 mL Single-dose Vialsndc 55513-741-10amgen®parsabivtm (etelcalcetide)injection5 mg/mlfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 03)

PARSABIV (etelcalcetide) Injection 5 mg/mL in 10 single-dose 1 mL vials, presented in a carton label. The product is an intravenous injection indicated for use after hemodialysis, sterile and preservative-free, labeled by Amgen, Inc. Storage instructions include keeping the unopened carton at 2°C to 8°C (36°F to 46°F) protected from light.*

FDA Label Image

Ndc 55513-742-10amgen®parsabivtm (etelcalcetide)injection10 mg/2 mLfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 04)

PARSABIV (etelcalcetide) Injection 10 mg/2 mL single-dose vials carton label. The label states it is for intravenous use after hemodialysis, preservative-free and sterile, with storage instructions at 2°C to 8°C (36°F to 46°F) in the original carton protected from light. Manufactured by Amgen, Inc. The NDC is 55513-742-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.